CAFs contribute to tumor progression by releasing cytokines such as TGF-β, IL-6, and IL-8, which promote proliferation, migration, immune evasion, and epithelial-mesenchymal transition (EMT). This evidence concerns the gene TGFB1 and neoplasm.